Yiming Zhang Selected Research

licogliflozin

1/2022	Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.
1/2019	The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiming Zhang Research Topics

Disease

29	Neoplasms (Cancer) 06/2022 - 07/2012
17	Prostatic Neoplasms (Prostate Cancer) 07/2021 - 04/2010
16	Inflammation (Inflammations) 11/2022 - 01/2015
12	Carcinogenesis 01/2022 - 10/2014
8	Wounds and Injuries (Trauma) 01/2022 - 06/2004
7	Obesity 08/2021 - 01/2018
6	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2014
6	Type 2 Diabetes Mellitus (MODY) 01/2019 - 07/2010
5	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2020
5	Epilepsy (Aura) 01/2020 - 01/2003
5	Atherosclerosis 01/2019 - 01/2011
4	Body Weight (Weight, Body) 03/2022 - 01/2011
4	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2012
4	Fibrosis (Cirrhosis) 01/2022 - 10/2018
4	Glioma (Gliomas) 01/2022 - 12/2019
4	Glucose Intolerance 01/2022 - 10/2016
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 04/2016
4	Hypoxia (Hypoxemia) 01/2021 - 11/2015
4	Premature Birth (Birth, Premature) 10/2020 - 03/2016
3	Anemia 04/2022 - 01/2018
3	Pain (Aches) 03/2022 - 12/2021
3	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2019
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 11/2020
3	Insulin Resistance 01/2022 - 01/2019
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2019
3	COVID-19 05/2021 - 10/2020
3	Overweight 01/2021 - 12/2019
3	Infections 01/2021 - 07/2017
3	Hepatocellular Carcinoma (Hepatoma) 11/2017 - 01/2016
2	Metabolic Diseases (Metabolic Disease) 04/2022 - 01/2019
2	Hemorrhage 02/2022 - 01/2019
2	Liver Diseases (Liver Disease) 01/2022 - 07/2017
2	Weight Loss (Weight Reduction) 01/2022 - 01/2019
2	Cancer Pain 01/2022 - 01/2022
2	Diarrhea 01/2022 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2011
2	Lymphoma (Lymphomas) 01/2021 - 08/2015
2	Contracture 01/2021 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2016
2	Cognitive Dysfunction 01/2021 - 05/2017
2	Dementia (Dementias) 01/2021 - 12/2019
2	Pregnancy Complications 10/2020 - 10/2018
2	Osteonecrosis (Kienbock's Disease) 10/2020 - 01/2019
2	Asthma (Bronchial Asthma) 09/2020 - 01/2013
2	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 05/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 06/2021 - 10/2014
13	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2010
11	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
9	Pharmaceutical PreparationsIBA 03/2022 - 12/2012
6	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
6	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2011
5	Insulin (Novolin)FDA Link 02/2021 - 01/2011
5	AntigensIBA 01/2021 - 12/2012
4	CytokinesIBA 01/2022 - 10/2015
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
4	Long Noncoding RNAIBA 01/2022 - 01/2017
4	sharpinIBA 07/2021 - 10/2014
4	Peptides (Polypeptides)IBA 05/2021 - 02/2011
4	SeleniumIBA 01/2021 - 04/2018
3	NF-kappa B (NF-kB)IBA 11/2022 - 02/2015
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 01/2016
3	Selenoproteins (Selenoprotein)IBA 01/2021 - 04/2018
3	Docetaxel (Taxotere)FDA Link 01/2021 - 10/2014
3	rhodiolosideIBA 01/2021 - 03/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2016
3	IronIBA 08/2020 - 01/2017
3	EnzymesIBA 08/2020 - 01/2003
3	LipidsIBA 01/2020 - 01/2011
3	OzoneIBA 01/2018 - 03/2016
3	Air Pollutants (Pollutants, Air)IBA 01/2018 - 01/2016
3	Valproic Acid (Depakote)FDA LinkGeneric 11/2004 - 01/2003
2	LipopolysaccharidesIBA 11/2022 - 06/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 06/2004
2	Arginine (L-Arginine)FDA Link 01/2022 - 01/2022
2	licogliflozinIBA 01/2022 - 01/2019
2	CalciumIBA 01/2022 - 01/2022
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2016
2	6-methyladenineIBA 01/2022 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2021 - 08/2015
2	Small Interfering RNA (siRNA)IBA 01/2021 - 05/2017
2	Capsules (Microcapsules)IBA 01/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 12/2017
2	Biological ProductsIBA 01/2021 - 01/2017
2	C-Reactive ProteinIBA 01/2021 - 10/2016
2	AndrogensIBA 01/2021 - 04/2010
2	Interleukin-4 (Interleukin 4)IBA 09/2020 - 01/2019
2	SteroidsIBA 08/2020 - 01/2019
2	TrehaloseIBA 01/2020 - 01/2019
2	CholesterolIBA 01/2020 - 10/2016
2	Competitive Endogenous RNAIBA 01/2020 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2019 - 06/2004
2	Mitogen-Activated Protein KinasesIBA 03/2019 - 12/2017
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 01/2011

Therapy/Procedure

14	Therapeutics 04/2022 - 07/2012
4	Drug Therapy (Chemotherapy) 01/2022 - 12/2012
4	Castration 01/2021 - 01/2016
3	Immunotherapy 01/2022 - 01/2021
2	Pain Management 01/2022 - 05/2021
2	Radiotherapy 01/2021 - 07/2012